LAWYER PROFILE

Hogan Lovells US LLP

Philip Katz

Washington, DC, USA

USA Guide 2021

Ranked in 2 departments

Lawyer profile for USA 2021

Profile view:

This individual is also ranked in:

Global 2022

Chambers Review

Chambers Research is conducted by 200 Research Analysts, across 200 jurisdictions and provides nearly 6,000 rankings tables. Annually we collect hundreds of thousands of responses from clients, the majority via in-depth interview. Learn more about our methodology.

USA

Healthcare: Pharmaceutical/Medical Products Regulatory - District of Columbia

Band 2

Philip Katz undertakes an array of FDA matters including issues relating to orphan drugs designation and regulatory exclusivity.
"He is an expert in FDA matters." "He has a longstanding practice on the pharmaceutical side, is well known and is a go-to lawyer." "He's a very good lawyer who provides sound, thoughtful advice."

Learn more about this team• View ranking table

Life Sciences: Regulatory/Compliance - USA - Nationwide

Band 3

Philip Katz is a seasoned guide for startups and public companies in the biotech and pharmaceuticals industries, frequently assisting clients in the navigation of FDA and other regulatory frameworks. He is well versed in Hatch-Waxman, orphan drug and biosimilars issues and is adept at representing clients in court and before various regulators.
"He is a very good lawyer who provides sound and thoughtful advice."

Learn more about this team• View ranking table

This individual is also ranked in:

Global 2022